Amyloid A protein amyloidosis induced in apolipoprotein-E-deficient mice.
暂无分享,去创建一个
D. Cui | T. Gondo | Y. Hoshii | M. Takahashi | T. Ishihara | K. Higuchi | H. Kawano | K. Kogishi | T. Takeda
[1] S. Tsuji,et al. Aβ1–40 but not Aβ1–42 levels in cortex correlate with apolipoprotein E ϵ4 allele dosage in sporadic Alzheimer's disease , 1997, Brain Research.
[2] R. Wetzel,et al. Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E. , 1996, Biochemistry.
[3] M. Esiri,et al. APOLIPOPROTEIN E IS ASSOCIATED WITH ISLET AMYLOID AND OTHER AMYLOIDOSES: IMPLICATIONS FOR ALZHEIMER'S DISEASE , 1996, The Journal of pathology.
[4] Y. Sakaki,et al. 'In vitro' amyloid fibril formation from transthyretin: the influence of ions and the amyloidogenicity of TTR variants. , 1996, Biochimica et biophysica acta.
[5] M. Kindy,et al. Association of apolipoprotein E with murine amyloid A protein amyloid. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[6] H. Brewer,et al. Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments , 1994, Nature.
[7] T Vogel,et al. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. , 1994, The American journal of pathology.
[8] T. Wisniewski,et al. Potential role of apolipoprotein-E in fibrillogenesis. , 1994, The American journal of pathology.
[9] R. Mahley,et al. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. , 1994, Science.
[10] R. Mahley,et al. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia. , 1994, The Journal of biological chemistry.
[11] F. Gejyo,et al. A monoclonal antibody recognizing apolipoprotein E peptides in systemic amyloid deposits. , 1994, Annals of clinical and laboratory science.
[12] D. Booth,et al. Human lysozyme gene mutations cause hereditary systemic amyloidosis , 1993, Nature.
[13] J. Liepnieks,et al. Hereditary renal amyloidosis associated with a mutant fibrinogen α–chain , 1993, Nature Genetics.
[14] N. Maeda,et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.
[15] N. Maeda,et al. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[16] Thomas Wisniewski,et al. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid , 1992, Neuroscience Letters.
[17] M. Key,et al. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[18] E. Otomo,et al. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease , 1991, Brain Research.
[19] H. Matsumiya,et al. Sandwich enzyme-linked immunosorbent assay of rat apolipoprotein E. , 1990, Biochemical medicine and metabolic biology.
[20] R. Mahley,et al. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.
[21] S. Prusiner,et al. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. , 1987, Laboratory investigation; a journal of technical methods and pathology.
[22] K. Reue,et al. Evolution of apolipoprotein E: mouse sequence and evidence for an 11-nucleotide ancestral unit. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[23] M. Skinner,et al. In vitro formation of amyloid fibrils from intact beta 2-microglobulin. , 1985, Biochemical and biophysical research communications.
[24] M. Skinner,et al. Further characterization of amyloid-enhancing factor. , 1982, Laboratory investigation; a journal of technical methods and pathology.
[25] K. Weisgraber. Apolipoprotein E: structure-function relationships. , 1994, Advances in protein chemistry.
[26] G. Glenner,et al. The 1990 Guidelines for Nomenclature and Classification of Amyloid and Amyloidosis , 1991 .
[27] R. Kisilevsky,et al. Sulfated glycosaminoglycans: a common constituent of all amyloids? , 1987, Laboratory investigation; a journal of technical methods and pathology.
[28] G. Glenner,et al. Amyloid. 3. A method for rapid induction of amyloidosis in mice. , 1968, International archives of allergy and applied immunology.